CA972758A - Process for the preparation of thienyl-imidazolylalkanoic acid deriviatives and compounds thereby produced - Google Patents

Process for the preparation of thienyl-imidazolylalkanoic acid deriviatives and compounds thereby produced

Info

Publication number
CA972758A
CA972758A CA129,259A CA129259A CA972758A CA 972758 A CA972758 A CA 972758A CA 129259 A CA129259 A CA 129259A CA 972758 A CA972758 A CA 972758A
Authority
CA
Canada
Prior art keywords
imidazolylalkanoic
thienyl
compounds
preparation
produced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA129,259A
Other languages
English (en)
Other versions
CA129259S (en
Inventor
Manfred Plempel
Werner Meiser
Karl H. Buchel
Carl Metzger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of CA972758A publication Critical patent/CA972758A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA129,259A 1970-12-05 1971-12-03 Process for the preparation of thienyl-imidazolylalkanoic acid deriviatives and compounds thereby produced Expired CA972758A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2059949A DE2059949C3 (de) 1970-12-05 1970-12-05 Thienyl-fettsäurederivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
CA972758A true CA972758A (en) 1975-08-12

Family

ID=5790107

Family Applications (1)

Application Number Title Priority Date Filing Date
CA129,259A Expired CA972758A (en) 1970-12-05 1971-12-03 Process for the preparation of thienyl-imidazolylalkanoic acid deriviatives and compounds thereby produced

Country Status (19)

Country Link
US (1) US3790594A (de)
JP (2) JPS5529049B1 (de)
AT (1) AT310156B (de)
AU (1) AU454611B2 (de)
BE (1) BE776212A (de)
CA (1) CA972758A (de)
CH (1) CH562820A5 (de)
CS (1) CS177073B2 (de)
DD (1) DD95569A5 (de)
DE (1) DE2059949C3 (de)
ES (1) ES397694A1 (de)
FR (1) FR2116548B1 (de)
GB (1) GB1320653A (de)
HU (1) HU162939B (de)
IL (1) IL38290A (de)
NL (1) NL7116591A (de)
PL (1) PL77004B1 (de)
SE (1) SE387343B (de)
SU (1) SU448646A3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1475271A (en) * 1975-04-30 1977-06-01 Pfizer Ltd 1-aryl-2-1-imidazolyl-alkyl ethers and thioethers and their use as antifungal agents
JPS59156411U (ja) * 1983-04-06 1984-10-20 皆川　巧 トラクタ用作業機連結装置の延長杆連結装置
DE3622791A1 (de) * 1986-07-07 1988-01-21 Heumann Pharma Gmbh & Co Neue 1,4-piperazinderivate, verfahren zu ihrer herstellung, ihre verwendung und diese verbindungen enthaltendes arzneimittel
US5710173A (en) * 1995-06-07 1998-01-20 Sugen, Inc. Thienyl compounds for inhibition of cell proliferative disorders
US6545163B1 (en) * 1995-10-02 2003-04-08 Napp Technologies Process to prepare 1-aryl-2-(1-imidazolyl) alkyl ethers and thioethers
WO1997036886A1 (en) * 1996-04-03 1997-10-09 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase

Also Published As

Publication number Publication date
SE387343B (sv) 1976-09-06
NL7116591A (de) 1972-06-07
SU448646A3 (ru) 1974-10-30
HU162939B (de) 1973-05-28
AT310156B (de) 1973-09-25
DE2059949A1 (de) 1972-06-15
FR2116548A1 (de) 1972-07-13
DD95569A5 (de) 1973-02-12
GB1320653A (en) 1973-06-20
ES397694A1 (es) 1975-03-16
PL77004B1 (de) 1975-02-28
CH562820A5 (de) 1975-06-13
US3790594A (en) 1974-02-05
FR2116548B1 (de) 1975-08-01
IL38290A0 (en) 1972-02-29
AU3560471A (en) 1973-05-17
JPS5529049B1 (de) 1980-07-31
IL38290A (en) 1975-02-10
JPS5711909B2 (de) 1982-03-08
AU454611B2 (en) 1974-10-31
BE776212A (fr) 1972-06-05
DE2059949C3 (de) 1979-12-13
JPS5498760A (en) 1979-08-03
DE2059949B2 (de) 1979-04-05
CS177073B2 (de) 1977-07-29

Similar Documents

Publication Publication Date Title
CA923139A (en) Process for the preparation of esters of the carbonic acid
CA1000301A (en) Process for the preparation of phenoxyalkylamines
CA924306A (en) Compounds of the dihydro-lysergic and -isolysergic acid series and process for preparing same
CA997375A (en) Process for the preparation of phenoxyalkylamines
CA953314A (en) Process for the preparation of 5-vinylnorbornene-2
CA972758A (en) Process for the preparation of thienyl-imidazolylalkanoic acid deriviatives and compounds thereby produced
CA922721A (en) Process for the preparation of 3-phenyl-5-t-butyl-2-oxadiazolones
CA960213A (en) Process for the preparation of 3-azolylpropynes and compounds thereby produced
CA1000302A (en) Process for the preparation of phenoxyalkylamines
CA960674A (en) Process for the preparation of isocarbostyrils
CA945143A (en) Process for the preparation of des-phenylalanin b1-insulin
CA1013752A (en) Process for the preparation of cycloalkanediones
CA958419A (en) Process for the preparation of 5-alkylidenenorbornene-2
CA948156A (en) Process for the preparation of polychlorcyclopentane and hexachlorcyclopentadiene
CA987445A (en) Process for the preparation of transpolypentenamer
CA951721A (en) Process for the preparation of 14-anhydrobufaline
CA837608A (en) Process for the preparation of penicillines
CA974987A (en) 15-oxoprost-13-enoic acid derivatives and process for the preparation thereof
CA856817A (en) Process for the preparation of 3-aminopyrazinoic acid
CA942316A (en) Process for the manufacture of 2-chloroethane-phosphonic acid
CA854710A (en) Process for the preparation of 7-aminocephalosporanic acid and its derivatives
CA858566A (en) Process for the preparation of 7-aminocephalosporanic acid
CA853197A (en) Process for the preparation of 7-aminocephalosporanic acid
CA850111A (en) Process for the preparation of triacrylyl perhydro-s-triazines
CA832487A (en) Process for the preparation of acrylophenones